Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vaira

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Gastroenterology|December 12, 1997
What is the role of Helicobacter pylori in complicated ulcer disease?D Vaira, M Menegatti, M Miglioli
Lancet (London, England)|September 12, 1992
Age-related increase of Helicobacter pylori frequency in symptom-free and in dyspeptic childrenG Oderda, D Vaira, J Holton
Gut|August 1, 1994
Duodenal ulcer, Helicobacter pylori, and gastric secretionK Chandrakumaran, D Vaira, M Hobsley
Gut|January 4, 2011
Sequential therapy for Helicobacter pylori eradication: is levofloxacin better?A Zullo, V De Francesco, D Vaira
Lancet (London, England)|January 27, 1996
IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Italian Helicobacter pylori Study GroupD Vaira, V Stanghellini, M Miglioli, et al.
Gut|October 9, 1998
The European meeting on Helicobacter pylori: therapeutic news from LisbonU Peitz, M Menegatti, D Vaira, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1997
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrointestinal symptoms. The Italian Helicobacter Pylori Study GroupD Palli, D Vaira, M Menegatti, et al.
Revue Medicale De Liege|December 3, 1998
["Hepatitis" A virus g: myth or reality? VHG/GBH-C: diagnosis, epidemiology, transfusion risk, and pathogenicity]C Gérard, D Vaira, J Delwaide, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2002
Review article: diagnosis of Helicobacter pylori infectionD Vaira, L Gatta, C Ricci, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1995
The susceptibility of Helicobacter pylori to the rifamycin, rifaximinJ Holton, D Vaira, M Menegatti, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Gastroenterology|December 12, 1997
What is the role of Helicobacter pylori in complicated ulcer disease?D Vaira, M Menegatti, M Miglioli
Lancet (London, England)|September 12, 1992
Age-related increase of Helicobacter pylori frequency in symptom-free and in dyspeptic childrenG Oderda, D Vaira, J Holton
Gut|August 1, 1994
Duodenal ulcer, Helicobacter pylori, and gastric secretionK Chandrakumaran, D Vaira, M Hobsley
Gut|January 4, 2011
Sequential therapy for Helicobacter pylori eradication: is levofloxacin better?A Zullo, V De Francesco, D Vaira
Lancet (London, England)|January 27, 1996
IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Italian Helicobacter pylori Study GroupD Vaira, V Stanghellini, M Miglioli, et al.
Gut|October 9, 1998
The European meeting on Helicobacter pylori: therapeutic news from LisbonU Peitz, M Menegatti, D Vaira, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1997
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrointestinal symptoms. The Italian Helicobacter Pylori Study GroupD Palli, D Vaira, M Menegatti, et al.
Revue Medicale De Liege|December 3, 1998
["Hepatitis" A virus g: myth or reality? VHG/GBH-C: diagnosis, epidemiology, transfusion risk, and pathogenicity]C Gérard, D Vaira, J Delwaide, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2002
Review article: diagnosis of Helicobacter pylori infectionD Vaira, L Gatta, C Ricci, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1995
The susceptibility of Helicobacter pylori to the rifamycin, rifaximinJ Holton, D Vaira, M Menegatti, et al.
Pageof 18